<DOC>
	<DOCNO>NCT01391390</DOCNO>
	<brief_summary>This double-blind , randomize , placebo-controlled trial melatonin add-on therapy antipsychotic perform examine effect melatonin tardive dyskinesia symptom cognitive deficit 120 patient establish tardive dyskinesia ( TD ) . This study address free radical hypothesis TD .</brief_summary>
	<brief_title>Melatonin Treatment Tardive Dyskinesia Schizophrenia</brief_title>
	<detailed_description>1 . Since propose neuroleptic-induced increase free-radical production may relate development TD , investigator hypothesize melatonin , effective antioxidant , may attenuate severity tardive dyskinesia symptom . 2 . Due increase cognitive deficit patient TD implication oxidative stress cognitive impairment , investigator hypothesize cognitive impairment tardive dyskinesia symptom may induce pathophysiological stimulus -- oxidative stress . Hence , investigator hypothesize tardive dyskinesia symptom cognitive deficit patient TD may improve melatonin simultaneously .</detailed_description>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>1. diagnosis schizophrenia TD ; 2. duration TD symptom longer 1 year ; 3. stable dos antipsychotic drug least 6 month ; 4. 18 70 year age . 1. comorbid neurological illness TD ; 2. receive vitamin C vitamin E within 1 month start study ; 3. alcohol/drug abuse ; 4. acute , unstable medical condition ; 5. pregnant breastfeed female ; 6. use antioxidant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Tardive Dyskinesia</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Antioxidant</keyword>
</DOC>